Review identifies ‘window of opportunity’ in early inflammatory arthritis
Doctors need to consider initiating early disease-modifying anti-rheumatic drug therapy in patients presenting with early inflammatory arthritis who are a high risk of developing rheumatoid arthritis, according to a review in Current Opinion in Rheumatology....
Want to read complete article? Please Sign in or Register.